Venlafaxine causing akathisia: A case report

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 24, Issue 3, 2012, Pages

  George, Mathew ^a   Campbell III, John J ^a  

^a MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VENLAFAXINE;

AGED; AGITATION; AKATHISIA; BARNES AKATHISIA RATING SCALE; CASE REPORT; CLINICAL FEATURE; CONTROLLED DRUG RELEASE; DEMENTIA; DEPRESSION; HOSPITAL ADMISSION; HUMAN; LETTER; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 84867525186     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11060144     Document Type: Letter

References (8)

1. Venlafaxine. Drugdex Evaluations. Micromedex 1.0 (Healthcare series). Greenwood Village, Colo; Thomson Reuters (Healthcare Inc.); accessed on July 27, 2011
2. Barnes TR: A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154:672-676
3. Ng J, Sansone RA, McDonald S: Akathisia and abnormal movements of the upper extremities with venlafaxine and methimazole. Gen Hosp Psychiatry 2009; 31:388-390
4. Hansen L: A critical review of akathisia and its possible association with suicidal behaviour. Hum Psychopharmacol 2001; 16:495-505
5. Ayd FJ Jr: A survey of drug-induced extrapyramidal reactions. JAMA 1961; 175:1054-1060
6. Tassin JP, Stinus L, Simon H, et al: Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res 1978; 141:267-281
7. Lane RM: SSRI-induced extrapyramidal side effects and akathisia: implications for treatment. J Psychopharmacol 1998; 12:192-214
8. Preskorn S, Patroneva A, Silman H, et al: Comparison of the pharmacokinetics of venlafaxine extended-release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers. J Clin Psychopharmacol 2009; 29:39-43